About Index Trending news
Analyze
Pricing
Celgene Corporation

Celgene Corporation

Work at Celgene Corporation? Add yourself to this profile

Celgene Corporation

Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site

Elsewhere

Alexa global traffic share

Twitter followers

22 Jun 2017
$68,000,000
Venture capital (Series A)

Quebec's Repare Therapeutics raises $68M in Series A funding

Fundnews
+1
29 Nov 2016
Undisclosed funding
Added by

Celgene Invests More in GNS Healthcare For Machine Learning Software

Xconomy
01 Sep 2016
$70,000,000
Venture capital (Series B)
Celgene, Foresite Capital, Invus, +6
Added by

Arcus Biosciences Raises $70M in Series B Funding

FinSMEs
08 Aug 2016
$37,000,000
Venture capital (Series B)

Startup targeting protein degradation in cancer raises $37M

MedCity News
+3
19 Jul 2016
$57,000,000
Venture capital (Series A)
Added by
12 Jul 2016
$22,500,000
Venture capital (Series A)
Celgene, Eshelman Ventures, Healthlink Capital, +1

New York Startup Sapience Therapeutics Nabs 22 5 Million Series A Financing

biospace
+1
17 May 2016

Agenovir Raises $10.6M in Series A Financing

FinSMEs
+2
04 May 2016
$46,000,000
Venture capital (Series A)
Added by
26 Apr 2016
$50,000,000
Venture capital (Series B)
Kleiner Perkins Caufield & Byers, Celgene, Topspin Partners, +1

Venture Capital Access Online | Venture Capital News

vcaonline
+1
05 Apr 2016
$220,000,000
Venture capital (Series B)

Venter's Human Longevity raises $220M with help from Celgene, Illumina

FierceBiotech
+1
04 Apr 2016
$220,000,000
Venture capital (Series B)
Added by

Human Longevity Raises over $220M in Series B Funding

FinSMEs
08 Jan 2016
$61,500,000
Venture capital (Series A)
Added by

Zymeworks snags huge $61.5 million Series A round

BetaKit
+2
30 Apr 2015
$41,800,000
Venture capital (Series D)
Added by

Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology MicroRNA Pipeline

Marketwire
28 Apr 2015
$64,000,000
Venture capital (Series B)
Added by

As patent battle brews, Celgene and GSK lead $64M raise for CRISPR Therapeutics

FierceBiotech
17 Dec 2014
$38,000,000
Venture capital (Series B)
Added by

Celgene Backed Startup Flexus Biosciences Secures 38 Million

biospace
+1
20 Oct 2014
Venture capital
Added by

Celgene Participates in New Round of Investment for Sequenta

businesswire
23 Sep 2014
$50,600,000
Venture capital (Series B)
Added by

SEC FORM D/A

sec